Abbott
ABTAbbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products.
Earnings
Next report
Oct 21, 2026 (in 2 months)Segments
Competitors
By market cap
By revenue growth
Profile
Abbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products. The company operates across the entire care continuum, providing branded generic pharmaceuticals, diagnostic systems, nutritional products, and advanced medical devices. Its core value proposition focuses on improving health outcomes through technological innovation and a broad presence in both developed and emerging markets.
Abbott is a diversified healthcare leader with dominant positions in continuous glucose monitoring and pediatric nutrition, competing through high-tech innovation and brand equity.
FAQ
- What is Abbott's market cap?
- Abbott (ABT) has a market capitalization of $197.44B and trades on NYSE.
- What is Abbott's revenue and profitability?
- Abbott generated $46.6B in trailing twelve-month revenue with net income of $5.4B, representing a net margin of 11.6%. Gross margin stands at 56.6%, with free cash flow of $7.8B. These figures are based on the Q2 2026 filing.
- Who are Abbott's competitors?
- Abbott's key competitors include Medtronic, Johnson & Johnson, Dexcom, and others. These companies compete in similar markets and product categories.
- Who does Abbott partner with?
- Abbott's notable partners include Exact Sciences Corporation.
- Where is Abbott headquartered?
- Abbott is headquartered in United States of America and employs approximately 114,000 people. It has been publicly traded since 1949.
